Try our beta test site

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2008 by University of Oxford.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
BioMarin Pharmaceutical
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00423280
First received: January 17, 2007
Last updated: August 6, 2008
Last verified: June 2008